CRISTELITA PARROCHO: Open Payments
NPI 1275929820 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,888 in 90 payments from 30 companies in 2025. Trend: 2023 $546 · 2024 $313 · 2025 $1,888
Food & beverage: $1,593Education: $295
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $176 |
| Celgene Corporation | 12 | $162 |
| Daiichi Sankyo Inc. | 9 | $150 |
| Exelixis Inc. | 2 | $119 |
| Incyte Corporation | 2 | $114 |
| Gilead Sciences, Inc. | 5 | $104 |
| SEAGEN INC. | 1 | $100 |
| PFIZER INC. | 8 | $92 |
| Genentech USA, Inc. | 4 | $91 |
| Merck Sharp & Dohme LLC | 4 | $85 |
Products named: Enhertu, REBLOZYL, Trodelvy, Fabhalta, KISQALI, VERZENIO, KEYTRUDA, VENCLEXTA.
Industry payments across TX — which companies pay providers there.
